| Competitors: | Renalytix (Reg S), SDI Group |
| Registrars: | Capita Registrars |
| CEO: | David Marsh |
| Chairman: | Jonathan Glenn |
| Group CFO: | Brent Greetham |
| Independent Non-Executive Director: | Keyvan Djamarani |
| Non-Executive Chairman: | Gordon Roy Davis |
| Non-Executive Dir: |
| Address: | Clayton Wood House, Clayton Wood Bank Rise, Leeds, United Kingdom, LS16 6QZ |
| Phone: | +44 (0) 113 230 7597 |
| Fax: | +44 (0) 113 230 7598 |
| Website: | http://www.sigroupplc.com/ |
| Sector: | Health Care(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0004016704 |
| Currency | UK Pounds |
| Share Price | 0.58p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 0.70 |
| 52 Week Low | 0.50 |
| Volume | 0 |
| Shares Issued | 932.82m |
| Market Cap | £5.36m |
| Beta | 0.53 |
| RiskGrade | 341 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| CEO | David Marsh |
| Chair | Jonathan Glenn |
You are here: research